IVIEW Therapeutics, Inc. is a company that provides Coronavirus disease 2019 (COVID-19), Antiseptic Agent, Information technology consulting and more. IVIEW Therapeutics, Inc. is headquartered in United States Pennsylvania. IVIEW Therapeutics, Inc. was founded in 2015. IVIEW Therapeutics, Inc. has a total of 48 patents
visualizing technology portfolio of hot application areas and blank areas for IVIEW Therapeutics, Inc.
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for IVIEW Therapeutics, Inc.
Sign up to view the full data
Free Trial Now
Download
IVIEW Therapeutics, Inc. Frequently Asked Questions
What technical fields has IVIEW Therapeutics, Inc. researched?
IVIEW Therapeutics, Inc. has researched the technical fields related toCoronavirus disease 2019 (COVID-19)Antiseptic AgentInformation technology consultingSystems designViral ConjunctivitisOphthalmologyDermatologyClinical trial
What is IVIEW Therapeutics, Inc.'s total number of patents?
IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis. The company was founded in 2015...
What is IVIEW Therapeutics, Inc.'s official website?